13F reference period
n/a
Security Snapshot
KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (APLT) Institutional Ownership
CUSIP: 03828A101
13F Institutional Holders and Ownership History from Q2 2019 to Q1 2026
Institutions Reporting
Shares (Excl. Options)
n/a
Price
$0.10
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- APLT
- Shares outstanding
- 143,223,667
- SEC-reported price per share
- $0.10
- Insider filing price
- $0.10
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- APLT - KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 03828A101.
- 13F reference-period holder data is not available.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder data for the Q2 2026 reference period is not available.
- Available periods remain in the history table; they do not substitute for the headline period.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
03828A101
13F reference period
n/a
13F holders
13D/G owners
11
CIK / CUSIP context first
APLT full holder history
KalVista Pharmaceuticals, Inc. SEC filings
KalVista Pharmaceuticals, Inc. company facts
KalVista Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03828A101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
APLT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 15% | +13% | $12,946,856 | +$1,644,911 | 21,403,300 | +15% | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 |
| Alyeska Investment Group, L.P. | 5.8% | $2,615,924 | 6,707,497 | Alyeska Investment Group, L.P. | 31 Dec 2024 | |||
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 4.3% | $1,755,000 | 6,500,000 | Alexandria Real Estate Equities, Inc. | 11 Dec 2025 | |||
| Propel Bio Management, LLC | 4.2% | $1,564,002 | 6,015,394 | Propel Bio Management, LLC | 29 Dec 2025 | |||
| BlackRock, Inc. | 3.7% | -54% | $1,003,183 | -$783,523 | 5,219,475 | -44% | BlackRock, Inc. | 30 Jun 2025 |
| VANGUARD GROUP INC | 3.3% | -34% | $1,473,225 | -$359,492 | 4,734,013 | -20% | The Vanguard Group | 30 Jun 2025 |
| Schonfeld Strategic Advisors LLC | 3.3% | -53% | $1,823,678 | -$1,596,482 | 4,676,097 | -47% | Schonfeld Strategic Advisors LLC | 31 Mar 2025 |
| PERCEPTIVE ADVISORS LLC | 2.4% | $1,115,400 | 2,860,000 | Perceptive Advisors LLC | 31 Dec 2024 | |||
| MORGAN STANLEY | 2.5% | -64% | $1,114,983 | -$2,323,072 | 2,858,931 | -68% | Morgan Stanley | 31 Jan 2025 |
| FRANKLIN RESOURCES INC | 1.7% | -70% | $781,326 | -$1,871,029 | 2,003,400 | -71% | Franklin Resources, Inc. | 31 Dec 2024 |
| JANUS HENDERSON GROUP PLC | 0% | -104% | $13,958 | -$4,706,957 | 35,791 | -100% | JANUS HENDERSON GROUP PLC | 31 Dec 2024 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
28
Headline period
n/a
Rows shown
1-25 of 28
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$5,294,094 | $0.10 | 0 |
| 2025 Q4 | 58,883,039 | $5,929,909 | -$23,764,068 | $0.10 | 50 |
| 2025 Q3 | 94,763,328 | $57,199,408 | +$5,274,176 | $0.60 | 69 |
| 2025 Q2 | 88,058,885 | $27,371,087 | -$7,459,469 | $0.31 | 72 |
| 2025 Q1 | 106,044,815 | $51,845,704 | -$6,334,916 | $0.49 | 89 |
| 2024 Q4 | 115,065,005 | $98,537,797 | -$63,025,089 | $0.86 | 116 |
| 2024 Q3 | 112,721,874 | $960,819,113 | +$78,176,113 | $8.50 | 125 |
| 2024 Q2 | 103,226,978 | $481,702,267 | +$36,985,908 | $4.67 | 92 |
| 2024 Q1 | 93,958,967 | $638,614,949 | +$241,302,453 | $6.80 | 88 |
| 2023 Q4 | 61,449,532 | $205,844,085 | +$29,840,415 | $3.35 | 83 |
| 2023 Q3 | 42,970,428 | $106,996,842 | +$29,101,733 | $2.49 | 54 |
| 2023 Q2 | 31,465,661 | $40,275,555 | +$15,796,729 | $1.28 | 38 |
| 2023 Q1 | 19,276,965 | $15,634,509 | -$232,317 | $0.81 | 34 |
| 2022 Q4 | 19,679,561 | $15,064,959 | -$2,201,503 | $0.76 | 37 |
| 2022 Q3 | 22,671,560 | $21,085,673 | -$3,749,758 | $0.93 | 38 |
| 2022 Q2 | 26,706,667 | $25,318,845 | +$12,989,524 | $0.95 | 46 |
| 2022 Q1 | 12,347,239 | $26,037,310 | -$34,487,329 | $2.11 | 68 |
| 2021 Q4 | 14,922,342 | $133,548,279 | -$7,772,547 | $8.95 | 67 |
| 2021 Q3 | 15,108,904 | $250,903,236 | -$6,255,939 | $16.60 | 66 |
| 2021 Q2 | 15,367,633 | $319,342,764 | +$10,194,603 | $20.78 | 68 |
| 2021 Q1 | 14,854,223 | $278,593,752 | +$51,374,327 | $18.76 | 66 |
| 2020 Q4 | 12,104,777 | $266,428,658 | -$1,610,604 | $22.01 | 67 |
| 2020 Q3 | 12,195,771 | $253,182,315 | -$6,258,655 | $20.76 | 66 |
| 2020 Q2 | 11,427,491 | $412,583,649 | +$78,213,106 | $36.15 | 71 |
| 2020 Q1 | 9,645,977 | $315,329,165 | +$155,281,170 | $32.69 | 62 |